CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 21,348	$ 21,355
Restricted cash and cash equivalents	100	100
Prepaid expenses and other current assets	1,157	1,589
Total current assets	22,605	23,044
Operating lease right-of-use assets	961	723
Goodwill	1,914	1,914
Deposits and other assets	521	594
Total assets	26,001	26,275
Current liabilities:
Accounts payable	2,127	2,144
Accrued expenses and other current liabilities	4,570	2,640
Operating lease liabilities	356	198
Acquired in-process research and development payable	5,500	0
Total current liabilities	12,553	4,982
Operating lease liabilities, non-current	680	610
Warrant liability	1	40
Contingent consideration	170	296
Total liabilities	13,404	5,928
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; Series A convertible preferred stock, 17,500 shares designated; no shares issued and outstanding at September 30, 2022 and December 31, 2021	0	0
Common stock, $0.0001 par value; 350,000,000 shares authorized, 20,588,247 and 15,895,637 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	2	2
Additional paid-in capital	183,378	158,948
Accumulated deficit	(170,783)	(138,603)
Total stockholders’ equity	12,597	20,347
Total liabilities and stockholders’ equity	$ 26,001	$ 26,275